Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07213635) titled 'Paracervical Injection and Opioid Use After Vaginal Hysterectomy for Prolapse' on Oct. 2.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Double (Participant, Outcomes Assessor).
Primary Sponsor: University of North Carolina, Chapel Hill
Condition:
Opioid Use
Surgical Recovery
Vaginal Hysterectomy
Prolapse Pelvic
Postoperative Pain
Intervention:
Drug: Bupivacaine-epinephrine
Recruitment Status: Not recruiting
Phase: Phase 4
Date of First Enrollment: October 2025
Target Sample Size: 56
Countries of Recruitmen...